Rat­tled by set­backs, Cel­gene turns to ex-Mer­ck R&D star Alise Re­icin to re­pair its dam­aged de­vel­op­ment rep

At a time when the ex­ec­u­tive crew at Cel­gene has rat­tled in­vestors with a se­ries of set­backs on clin­i­cal de­vel­op­ment, the big biotech is re­or­ga­niz­ing its lead­er­ship on drug de­vel­op­ment and turn­ing to a for­mer Mer­ck R&D star to lead the way out of the wilder­ness.

Alise Re­icin, who played a ma­jor role in the big de­vel­op­ment cam­paign for Mer­ck’s Keytru­da, is be­ing placed in charge of the crit­i­cal mid- to late-stage de­vel­op­ment work at Cel­gene, where it’s been ex­pe­ri­enc­ing its biggest prob­lems.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER